Symbenda Post-Marketing Surveillance (PMS)

Clinical trial NCT02434484 · COMPLETED

Trial details

NCT number: NCT02434484
Sponsor: Eisai Korea Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Lymphoma, Non-Hodgkin Lymphocytic Leukemia Multiple Myeloma

Start date: 2018-07-04
Primary completion: 2020-03-20
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.